from time to time I have come to the floor to discuss our progress since we became the majority as Democrats in the Senate. I wanted to talk briefly about the accomplishments during this work period and the list of items we have attempted to address over the course of the now virtually 1 year that we have been in the majority. We took over officially during the month of July of last year. Technically, we are not quite there. But for all intents and purposes, we have now completed 1 year as a majority in the Senate. We began June with work on the supplemental appropriations bill, a key piece of legislation. That legislation passed in the Senate a couple of weeks ago. We then moved on to terrorism insurance. We passed that bill out of the Senate with an overwhelming vote. We passed legislation which expedites the extradition of terrorist suspects. The antiterrorism legislation passed about 10 days ago. We increased the debt limit on an overwhelmingly bipartisan basis. We passed the Defense authorization bill, thanks to the extraordinary leadership of our colleague from Michigan, Senator Levin. I might add that all of these issues--the supplemental appropriations, the terrorism insurance bill, the antiterrorism bill, the debt limit, and the Defense authorization bill--passed with overwhelming bipartisan majorities.
Thomas Daschle: “from time to time I have come to the floor to discuss our progress since we became the majority as Democrats in the…”
Editor's note · Context
Discussing the accomplishments of the Democratic majority in the Senate after one year in office.
Share
More from Thomas Daschle
I want to re-instate a science-driven environment. I want to take ideology and politics as much as humanly possible out of the process.
It will use Social Security and Medicare surpluses. It will create the same deficit situation, I promise you, as we have seen all through the 1980s and early `90s.
We have cost problems. We have access problems. But as you rightfully point out in your question, we certainly have quality problems.
As we look to ways with which to bring down costs, I am absolutely convinced that a big part of that effort... will be determined by the degree to which generic drugs are allowed to play the role that it can.





